Latest Announcements

Eveready Industries India Ltd reported Q1 FY27 earnings, with revenue at INR407.7 crores, a 9% YoY growth, and EBITDA margin of 15.1%. The company maintained its seventh consecutive quarter of year-on-year revenue growth, with the battery business delivering a strong quarter, recording 11.9% revenue growth.

Suraj Industries Ltd has announced an Investor Presentation Q1FY27, highlighting its growth opportunities in the Rajasthan market, expansion of manufacturing capabilities, and strategic partnerships. The company aims to become a fully integrated alco-bev player, with a net revenue target of >9x in FY27.

Talbros Automotive Components Ltd has announced its Q1 FY27 earnings conference call transcript, highlighting the company's strong performance in the Indian automotive industry, with growth in passenger and commercial vehicle sales, and increasing adoption of electric vehicles.

Om Freight Forwarders Ltd reported Q1FY27 financial results with revenue jumping 105% YoY to Rs. 193.35 Cr, EBITDA increasing 104% YoY to Rs. 11.29 Cr, and PAT growing 126% YoY to Rs. 7.30 Cr.

International Conveyors Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing revenue from operations of ₹3,780 lakhs, a 39.5% increase from the same period last year. The company's net profit after tax stood at ₹12,022 lakhs, a 123.5% increase from the same period last year.

Prakash Pipes Limited has announced its financial results for the quarter ended 30th June, 2026, with net sales of ₹241 crores, EBITDA of ₹27 crores, and profit after tax of ₹16 crores, registering growth of 19%, 47%, and 59% respectively over the corresponding quarter of the last financial year.

Kalpataru Projects International Limited (KPIL) has secured new orders worth ₹ 3,526 crores, including EPC orders for an industrial plant and residential building orders in India. The company's MD & CEO, Manish Mohnot, expressed delight with the strong order momentum in their T&D and B&F businesses.

Desco Infratech Ltd has received a purchase order/service order worth Rs. 21.42 million from KP Energy Ltd, Adani Total Gas Ltd, and Maharashtra Natural Gas Ltd for supply and installation works, MDPE pipeline, and underground PE pipeline projects.

Prakash Pipes Ltd has announced capacity expansion in its Flexible Packaging Division at Kashipur, involving a capital expenditure of around Rs. 100 Crores. The company has also reported unaudited financial results for the quarter ended 30th June, 2026, with a net profit of Rs. 1,642 lakhs.

Rasi Electrodes Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, reporting a net profit of Rs. 133.45 lakhs, a 76.5% increase from the previous quarter's net profit of Rs. 75.57 lakhs. The company's revenue from operations stood at Rs. 1,763.57 lakhs, a 4.7% increase from the previous quarter's revenue of Rs. 1,856.39 lakhs.

Dev Information Technology Ltd has reported its unaudited financials for Q1 FY27, with consolidated total income of ₹44.64 Cr, EBITDA of ₹3.99 Cr, and net profit of ₹2.11 Cr.

Baroda Rayon Corporation Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, with a net profit of ₹1,847.27 lakhs, a 283% increase from the same period last year.

Vedanta Ltd has been declared as the successful bidder for the Punnam Manganese Block in Andhra Pradesh after fulfilling statutory compliances. The block spans 152 hectares and is at the G4 stage of exploration. This acquisition will strengthen Vedanta's metals and mining portfolio and contribute to India's growing manganese requirements.

Natco Pharma Ltd announced unaudited financial results for Q1 FY27, with consolidated revenue of ₹794.4 Crore and profit after tax of ₹206.5 Crore. The company declared an interim dividend of ₹1.5 per equity share. The Board also approved the reconstitution of Risk Management Committee and Environment, Social and Governance Committee.

Prakash Pipes Ltd has announced unaudited financial results for the quarter ended 30.06.2026, with a net profit of ₹1,642 lakhs, a 21.5% increase from ₹1,348 lakhs in the previous quarter. The company has also approved a capacity expansion in the Flexible Packaging Division at Kashipur, involving a capital expenditure of around ₹100 Crores.

Sri Lotus Developers and Realty Ltd has been appointed as the developer for a prestigious residential re-development project at Shivaji Park Beach Front, expected to strengthen the company's presence in the luxury real estate segment and enhance long-term stakeholder value.

Meera Industries Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of ₹95.63 lakhs and a profit after tax of ₹71.34 lakhs. The company's revenue from operations was ₹1,234.59 lakhs, and its expenses were ₹1,158.82 lakhs. The results are available on the company's website and will be published in newspapers as per the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Lakshmi Mills Company Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with a net profit of Rs. 5,014.99 lakhs. The company's income from operations was Rs. 5,971.91 lakhs, while its expenditure was Rs. 5,603.43 lakhs. The unaudited financial results were approved by the Board of Directors at their meeting held on 14th August 2026.

Globe Civil Projects Ltd has announced its unaudited standalone and consolidated financial results for Q1 FY 27, with total income of ¥929 million and PAT of ¥71 million, representing a 37.26% and 40.42% YoY growth respectively.

Alkem Laboratories Ltd reported a 10.9% YoY growth in total revenue from operations for Q1FY27, with a 11% revenue growth in Q1FY27. The company outperformed the Indian Pharmaceutical Market (IPM) in seven key focused therapies. The EBITDA margin was 20.5%, a growth of 3.7% YoY. The net profit (after Non-Controlling interest) was ₹5,200 million, with a YoY de-growth of 21.7%. The company has outperformed IPM in seven key focused therapies: Anti-infectives grew by ~1.1X; Gastro-intestinal grew by ~1.2X, VMN ~1.4X, Pain ~1.8X, Anti-Diabetic ~1.4X, Respiratory ~1.6X and Derma ~1.6X.